PMH40 COST-UTILITY ANALYSIS (CUA) OF SERTINDOLE IN THE TREATMENT OF SCHIZOPHRENIA IN POLAND IN GENERAL POPULATION OF SCHIZOPHRENIC PATIENTS AND POPULATION OF PATIENTS INTOLERANT TO AT LEAST ONE OTHER ANTIPSYCHOTIC AGENT- A FIVE-YEAR MARKOV ...
Nov 1, 2010, 00:00 AM
10.1016/S1098-3015(11)72917-5
https://www.valueinhealthjournal.com/article/S1098-3015(11)72917-5/fulltext
Section Title :
RESEARCH POSTER ABSTRACTS
Section Order :
1076
First Page :
A453
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)72917-5&doi=10.1016/S1098-3015(11)72917-5